Glucose control and use of continuous glucose monitoring in the intensive care unit: A critical review

Current Diabetes Reviews

Volumn 4, Issue 3, 2008, Pages 234-244

  De Block, Christophe ^a,b   Manuel y Keenoy, Begoña ^b   Rogiers, Peter ^c   Jorens, Philippe ^a   Van Gaal, Luc ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Glucose levels; Glucose Monitoring; Insulin therapy; Intensive Care Unit (ICU); Normoglycemia; Stress hyperglycemia

Indexed keywords

ASCORBIC ACID; CORTICOSTEROID; DOPAMINE; GLUCOSE; HYPERTENSIVE FACTOR; INSULIN; MANNITOL; PARACETAMOL; POTASSIUM; SALICYLIC ACID;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTINUOUS BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DRUG DOSE TITRATION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; MORBIDITY; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRESS HYPERGLYCEMIA; STROKE; TRAUMATOLOGY; VALIDATION STUDY;

BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; INSULIN; INTENSIVE CARE UNITS; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; MONITORING, AMBULATORY; PREVALENCE; STRESS, PHYSIOLOGICAL;

EID: 54749099646     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339908785294460     Document Type: Review

References (137)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.
2. Egi M, Bellomo R, Stachowski E, et al. Intensive insulin therapy in postoperative intensive care unit patients. Am J Respir Crit Care Med 2006; 173: 407-13.
3. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-61.
4. Ligtenberg JJM, Meijering S, Stienstra Y, et al. Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 2006; 32: 435-38.
5. Cely CM, Arora P, Quartin AA, Kett DH, Schein RMH. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2006; 126: 879-87.
6. De Block C, Manuel-y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit. Assessment by continuous glucose monitoring. Diabetes Care 2006; 29: 1750-56.
7. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041-47.
8. Freire AX, Bridges L, Umpierrez GE, Kuhl D, Kitabchi AE. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005; 128: 3109-16.
9. Christiansen C, Toft P, Jørgensen HS, Andersen SK, Tønnesen E. Hyperglycemia and mortality in critically ill patients. A prospective study. Intensive Care Med 2004; 30: 1685-8.
10. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogenous population of critically ill patients. Mayo Clin Proc 2003; 78: 1471-78.
11. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82.
12. Whitcomb BW, Kimbrough Pradhan E, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005; 33: 2772-77.
13. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005; 80: 1558-67.
14. Mitchell I, Finfer S, Bellomo R, Highlett T, ANZICS clinical trials group glucose management investigators. Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study. Intensive Care Med 2006; 32: 867-74.
15. Zimmerman CR, Mlynarek ME, Jordan JA, Rajda CA, Horst HM. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother 2004; 38: 1123-29.
16. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22: 607-12.
17. Swenne CL, Lindholm C, Borowiec J, Schnell AE, Carlsson M. Peri-operative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. J Hosp Infect 2005; 61: 201-12.
18. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003; 55: 33-38.
19. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56: 1058-62.
20. Sung J, Bochicchio G, Joshi M, Bochicchio K, Tracy K, Scalea T. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59: 80-3.
21. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118: 173-79.
22. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146: 30-34.
23. Ruiz Magro P, Aparicio Lopez C, Lopez-Herce Cid J, Martinez Campos M, Sancho Perez L. Metabolic changes in critically ill children. An Esp Pediatr 1999; 51: 143-48.
24. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004; 5: 329-36.
25. Hall NJ, Peters M, Eaton S, Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004; 39: 898-901.
26. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-44.
27. Stranders I, Diamant M, van Gelder RE, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164: 982-88.
28. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. BMJ 1986; 293: 917-22.
29. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885-88.
30. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981; 246: 1690-93.
31. Sewdarsen M, Vythilingum S, Jialal I, Becker PJ. Prognostic importance of admission plasma glucose in diabetic and nondiabetic patients with acute myocardial infarction. Q J Med 1989; 71: 461-66.
32. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993; 94: 265-73.
33. Suskin N, McKelvie RS, Burns RJ, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000; 21: 1358-75.
34. Allport L, Baird T, Butcher K, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006; 29: 1839-44.
35. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004; 33: 71-77.
36. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KGMM, Gray CS. Prevalence of admission hyperglycemia across clinical subtypes of acute stroke. Lancet 1999; 353: 376-77.
37. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208-14.
38. Toni D, Sacchetti ML, Argentino C, et al. Does hyperglycemia play a role on the outcome of acute ischaemic stroke patients? J Neurol 1992; 239: 382-86.
39. Matchar DB, Divine GW, Heyman A, Feussner JR. The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med 1992; 117: 449-56.
40. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study. Neurology 1994; 44: 626-34.
41. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994; 25: 1977-84.
42. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67: 352-62.
43. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-18.
44. Devos P, Preiser JC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care 2007; 10: 206-9.
45. Clement S, Braithwaite SS, Magee MF, et al. on behalf of the Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-91.
46. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533-51.
47. Lewis KS, Kane-Gill SL, Bobek MB, Dasta JF. Intensive insulin therapy for critically ill patients. Ann Pharmacother 2004; 38: 1243-51.
48. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Review. Eur J Endocrinol 2000; 143: 1-13.
49. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-24.
50. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004; 30: 748-56.
51. Turina M, Christ-Crain M, Polk HC. Diabetes and hyperglycemia: strict glycemic control. Crit Care Med 2006; 34[Suppl]: S291-S300.
52. Das UN. Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Med Sci Monit 2003; 9: RA181-92.
53. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005; 115: 1111-19.
54. Frankenfeld DC, Reynolds HN, Badellino N, Wiles CE. Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. Intensive Care Med 1995; 21: 1016-22.
55. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114: 1187-95.
56. Mizock BA. Blood glucose management during critical illness. Rev Endocr Metab Disorders 2003; 4: 187-94.
57. Dandona P, Aljada A, Bandyopadhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care 2003; 26: 516-19.
58. Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 2006; 9: 124-30.
59. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132: 268-78.
60. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-78.
61. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-40.
62. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356-61.
63. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-502.
64. Capes S, Hunt D, Malmberg K, Pathak P, Gerstein H. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. A systematic overview. Stroke 2001; 32: 2426-32.
65. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58: 921-24.
66. Malmberg K, Rydén L, Efendic S, et al. A randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DI-GAMI study): effects of mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
67. Mehta SR, Yusuf S, Diaz R, et al. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-46.
68. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 2007; 146: 233-43.
69. Van den Berghe G. Does fight blood glucose control during cardiac surgery improve patient outcome? Ann Intern Med 2007; 146: 307-8.
70. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units. Diabetes 2006; 55: 3151-59.
71. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
72. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33: 711-15.
73. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-52.
74. Lacherade JC, Jabre P, Bastuji-Garin S, et al. Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med 2007; 33: 814-21.
75. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-66.
76. Vanhorebeek I, Langouche L, Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome in critical illness. Curr Opin Crit Care 2005; 11: 304-11.
77. Brunkhorst FM, Engel C, Bloos F, et al. for the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39.
78. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy 2007; 35[Suppl]: S503-S507.
79. Krinsley JS, Grover A. Severe hypoglycaemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262-67.
80. Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med 2006; 34: 2974-78.
81. Mechanick JI, Handelsman Y, Bloomgarden ZT. Hypoglycemia in the intensive care unit. Curr Opin Clin Nutr Metab Care 2007; 10: 193-96.
82. Vriesendorp TM, deVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycaemia in an intensive care unit. Crit Care Med 2006; 34: 2714-18.
83. Verbruggen SCAT, Joosten KFM, Castillo L, van Goudoever JB. Insulin therapy in the pediatric intensive care unit. Clin Nutr 2007; 26: 677-90.
84. Cochran A, Scaife ER, Hansen KW, Downey EC. Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma 2003; 55: 1035-38.
85. Alaedeen DI, Walsh MC, Chwals WJ. Total parenteral nutrition-associated hyperglycemia correlates with prolonged mechanical ventilation and hospital stay in septic infants. J Pediatr Surg 2006; 41: 239-44.
86. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 2005; 6: 470-72.
87. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma 2005; 59: 1148-54.
88. Binder ND, Raschko PK, Benda GI, Reynolds JW. Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 1989: 114: 273-80.
89. Collins Jr JW, Hoppe M, Brown K, Edidin DV, Padbury J, Ogata ES. A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 1991; 118: 921-27.
90. Meetze W, Bowsher R, Compton J, Moorehead H. Hyperglycemia in extremely-low-birth-weight infants. Biol Neonate 1998; 74: 214-21.
91. Ng SM, May JE, Emmerson AJ. Continuous insulin infusion in hyperglycemic extremely-low-birth-weight neonates. Biol Neonate 2005; 87: 269-72.
92. Thabet F, Bourgeois J, Guy B, Putet G. Continuous insulin infusion in hyperglycemic very-low-birth-weight infants receiving parenteral nutrition. Clin Nutr 2003; 22: 545-47.
93. Vaucher YE, Walson PD, Morrow 3rd G. Continuous insulin infusion in hyperglycemic, very low birth weight infants. J Pediatr Gastroenterol Nutr 1982; 1: 211-17.
94. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervouw system of intensive care patients. Neurology 2005; 64: 1348-53.
95. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175: 480-89.
96. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46: 335-43.
97. Walia S, Sutcliffe AJ. The relationship between blood glucose, mean arterial pressure and outcome after severe head injury: an observational study. Injury 2002; 33: 339-44.
98. Reed CC, Stewart RM, Sherman M, et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007; 204: 1048-54.
99. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Diabetes Care 2006; 29: 1955-62.
100. Meijering S, Corstjens AM, Tulleken JE, Meertens JHJM, Zijlstra JG, Ligtenberg JJM. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Critical Care 2006; 10: R19: 1-7.
101. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-27.
102. Goldberg PA, Siegel M, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27: 461-67.
103. Goldberg PA. Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocr Pract 2006; 12 (Suppl 3): 79-85.
104. Kanji S, Singh A, Tierney M, Meggison H, McIntyre L, Hebert PC. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004; 30: 804-10.
105. Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29: 271-76.
106. Hovorka R, Kremen J, Blaha J, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab 2007; 92: 2960-64.
107. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Tight glycemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Critical Care 2007; 11: R75.
108. Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak 2005; 5: 38.
109. Lonergan T, Compte AL, Willacy M, et al. A pilot study of the SPRINT protocol for tight glycemic control in critically ill patients. Diabetes Technol Ther 2006; 8: 449-62.
110. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004; 2(Suppl. 10): 71-80.
111. Brown G, Dodek P: Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med 2001; 29: 1714-19.
112. Chant C, Wilson G, Friedrich JO: Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy 2005; 25: 352-59.
113. Davidson PC, Steed RD, Bode BW: Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005; 28: 2418-23.
114. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 2002; 8: 10-18.
115. Osburne RC, Cook CB, Stockton L, et al. Improving hyperglycemia management in the intensive care unit: preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. Diabetes Educ 2006; 32: 394-403.
116. McMullin J, Brozek J, McDonald E, et al. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care 2007; 22: 112-19.
117. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols: Diabetes Care 2007; 30: 1005-1011.
118. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006; 98: 557-564.
119. Smith SM, Oveson KE, Strauss W, et al. Ultradian variation of blood glucose in intensive care unit patients receiving insulin infusions. Diabetes Care 2007; 30: 2503-2505.
120. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005; 33: 2778-85.
121. Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev 2001; 17: 113-23.
122. Steil GM, Rebrin K, Hariri F, et al. Interstitial fluid glucose dynamics during insulin-induced hypoglycemia. Diabetologia 2005; 48: 1833-40.
123. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003; 52: 2790-94.
124. De Block CEM, Manuel y Keenoy B, Rogiers P, Van Gaal LF. Intensive insulin therapy in the Intensive Care Unit: Assessment by continuous glucose monitoring. Response to Radermecker. Diabetes Care 2006; 29: 2763-64.
125. Rossetti P, Porcellati F, Fanelli CG, Bolli GB. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. Diabetes Technol Ther 2006; 8: 326-37.
126. Diabetes in Research Children Network (DirectNet) Study Group. Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006; 8: 318-25.
127. Feldman B, Brazg R, Schwartz S, Weinstein R. A continuous glucose sensor based on Wired Enzyme™ technology - Results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003; 5: 769-79.
128. Goldberg PA, Siegel M, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther 2004; 6: 339-47.
129. Vriesendorp T, deVries JH, Holleman F, Dzoljic M, Hoekstra J. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 2005; 7: 315-22.
130. Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2005; 90: 307-10.
131. Baumeister FAM, Rolinski B, Busch R, Emmrich P. Glucose monitoring with long-term microdialysis in neonates. Pediatrics 2001; 108: 1187-92.
132. Javid PJ, Halwick DR, Betit P, et al. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol Ther 2005; 7: 421-39.
133. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003; 7: 43-53.
134. Corstjens AM, Ligtenberg JJM, van der Horst ICC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill patients. Crit Care 2006; 10: R135.
135. Van Herpe T, Espinoza M, Haverbeke N, De Moor B, Van den Berghe G. Glycemia prediction in critically ill patients using an adaptive modeling approach. J Diabetes Sci Technol 2007; 1: 348-56.
136. Wilson DM, Block J. Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going? Diabetes Technol Ther 2005; 7: 788-91.
137. Hirsch IB. Algorithms for care in adults using continuous glucose monitoring. J Diabetes Sci Technol 2007; 1: 126-29.